CD38 and acute myeloid leukemia: CD38 CAR T cells can also be used for the treatment of T ALL and AML [113], but they are associated with a broader spectrum of toxicities in the lymphoid and myeloid compartment and leads to fratricide of early T cell progenitor cells [112].